Sientra (SIEN) to Release Quarterly Earnings on Thursday

Posted by MarketBeat News on Aug 4th, 2022

Sientra (NASDAQ:SIEN – Get Rating) will issue its quarterly earnings data after the market closes on Thursday, August 11th. Analysts expect the company to announce earnings of ($0.23) per share for the quarter. Sientra has set its FY 2022 guidance at EPS.Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Sientra (NASDAQ:SIEN – Get Rating) last issued its quarterly earnings results on Thursday, May 12th. The medical instruments supplier reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.03). Sientra had a negative return on equity of 498.54% and a negative net margin of 71.61%. The company had revenue of $21.40 million during the quarter, compared to the consensus estimate of $20.25 million. On average, analysts expect Sientra to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Sientra Stock Performance

Shares of SIEN opened at $1.06 on Thursday. The company has a quick ratio of 0.95, a current ratio of 1.59 and a debt-to-equity ratio of 2.61. The business’s 50 day moving average price is $0.92 and its 200-day moving average price is $1.77. Sientra has a 52 week low of $0.70 and a 52 week high of $7.95. The stock has a market cap of $66.40 million, a P/E ratio of -1.07 and a beta of 1.94.

Institutional Investors Weigh In On Sientra

Institutional investors have recently bought and sold shares of the business. Mirabella Financial Services LLP purchased a new stake in Sientra in the 1st quarter worth $26,000. Advisor Group Holdings Inc. boosted its holdings in shares of Sientra by 230.9% during the 1st quarter. Advisor Group Holdings Inc. now owns 11,930 shares of the medical instruments supplier’s stock valued at $26,000 after purchasing an additional 8,325 shares during the last quarter. Bank of Montreal Can boosted its holdings in shares of Sientra by 66.7% during the 1st quarter. Bank of Montreal Can now owns 66,589 shares of the medical instruments supplier’s stock valued at $151,000 after purchasing an additional 26,649 shares during the last quarter. Blair William & Co. IL boosted its holdings in shares of Sientra by 20.1% during the 1st quarter. Blair William & Co. IL now owns 77,645 shares of the medical instruments supplier’s stock valued at $172,000 after purchasing an additional 13,000 shares during the last quarter. Finally, Panagora Asset Management Inc. bought a new position in shares of Sientra during the 1st quarter valued at about $182,000. Hedge funds and other institutional investors own 82.42% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on SIEN shares. Maxim Group reaffirmed a “buy” rating and issued a $5.00 price objective on shares of Sientra in a research report on Friday, May 13th. StockNews.com lowered shares of Sientra from a “hold” rating to a “sell” rating in a research note on Tuesday, May 10th. Canaccord Genuity Group decreased their target price on shares of Sientra from $8.00 to $5.00 in a research note on Friday, May 13th. Finally, Lake Street Capital assumed coverage on shares of Sientra in a research note on Thursday, April 14th. They set a “buy” rating and a $8.00 target price for the company. One equities research analyst has rated the stock with a sell rating and six have assigned a buy rating to the company. According to MarketBeat.com, Sientra has a consensus rating of “Moderate Buy” and a consensus target price of $7.29.

About Sientra

(Get Rating)

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.